IGF2BP3 and colorectal carcinoma: Together, these findings indicate that mollugin inhibits the IGF2BP3/GPX4 (insulin-like growth factor 2 mRNA-binding protein 3/glutathione peroxidase 4) axis and induces ferroptosis in CRC cells, establishing its effective chemotherapeutic potential [18].